Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1373874

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1373874

Global Parenteral Nutrition Market Size, Share, Growth Analysis, By Consumer(Children and Newborns, and Adults), By End user(Clinics, Hospitals) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Parenteral Nutrition Market size was valued at USD 6.33 Billion in 2021 and is poised to grow from USD 6.71 Billion in 2022 to USD 10.7 Billion by 2030, at a CAGR of 6.0% during the forecast period (2023-2030).

The global parenteral nutrition market has experienced significant growth over the past years and is expected to continue expanding in the coming years. One of the key drivers fueling the growth of the global parenteral nutrition market is the increasing prevalence of chronic diseases and gastrointestinal disorders. Conditions such as cancer, Crohn's disease, and short bowel syndrome necessitate the use of parenteral nutrition to ensure adequate nutrition and support patient recovery. Moreover, the rising geriatric population, who are more prone to malnutrition and related complications, has contributed to the market growth. Another factor driving market expansion is the advancements in parenteral nutrition formulations and technologies. Manufacturers are focusing on developing innovative products that improve patient outcomes, reduce complications, and enhance the ease of administration. For instance, the introduction of multi-chamber bags that allow for customized nutrient combinations has simplified the process of preparing parenteral nutrition solutions, benefiting both healthcare professionals and patients. However, the global parenteral nutrition market also faces several challenges. One of the significant hurdles is the risk of infections and complications associated with long-term parenteral nutrition therapy. Catheter-related bloodstream infections and metabolic complications pose substantial risks to patients, requiring stringent infection control measures and careful monitoring. Furthermore, the high cost of parenteral nutrition solutions and associated equipment can limit market growth, especially in developing regions with limited healthcare budgets.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Parenteral Nutrition Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Parenteral Nutrition Market Segmental Analysis

The global parenteral nutrition market is segmented on the basis of consumer, end user, and region. By consumer, the market is segmented into Children and Newborns, and Adults. By end user, the market is segmented into Clinics, Hospitals, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Parenteral Nutrition Market Dynamics

Drivers of the Global Parenteral Nutrition Market

Technological Advancements in Parenteral Nutrition Products

The development of innovative formulations, improved nutrient combinations, and advanced delivery systems has enhanced the safety and efficacy of parenteral nutrition therapy. These advancements have made parenteral nutrition administration more convenient for healthcare providers and more tolerable for patients.

Increasing Awareness about Clinical Nutrition

There is a growing awareness of the importance of nutrition in overall health and disease management. This increased understanding of the role of nutrition in patient outcomes has led to a higher demand for parenteral nutrition therapy as a part of comprehensive healthcare.

Restraints in the Global Parenteral Nutrition Market

Regulatory Constraints and Lack of Standardization

Variations in regulations and lack of standardized guidelines for parenteral nutrition therapy across different regions pose challenges for manufacturers and healthcare providers. Harmonization of regulatory frameworks and the development of evidence-based guidelines are essential for ensuring safe and effective administration of parenteral nutrition.

Potential Complications and Limitations of Long-term Use

Prolonged dependence on parenteral nutrition may present complications such as liver dysfunction, fluid imbalances, and electrolyte abnormalities. These limitations and complications need to be carefully managed to ensure the optimal use of parenteral nutrition and minimize risks to patients.

Market Trends of Global Parenteral Nutrition Key

Integration of Digital Health Technologies: Digital health technologies, such as mobile applications, connected devices, and telehealth solutions, are being integrated into parenteral nutrition therapy. These technologies enable remote monitoring, real-time data collection, and improved communication between patients, caregivers, and healthcare providers, leading to better patient management and enhanced treatment outcomes.

Focus on Quality Control and Product Safety: With the increasing importance of patient safety, there is a growing focus on quality control and product safety in the manufacturing and administration of parenteral nutrition solutions. Companies are implementing stringent quality assurance processes, adhering to regulatory guidelines, and investing in technologies to ensure the safety and efficacy of their products.

Product Code: SQMIG35C2016

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Parenteral Nutrition Market by Consumer
    • Market Overview
    • Children and Newborns
    • and Adults
  • Global Parenteral Nutrition Market by End user
    • Market Overview
    • Clinics
    • Hospitals
    • and Others
  • Global Parenteral Nutrition Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Fresenius Kabi (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Baxter International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Grifols SA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Otsuka Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Aculife Healthcare Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Vifor Pharma (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sichuan Kelun Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • ALLERGAN (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Claris Lifesciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Actavis plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • ABBOTT (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Beximco Pharmaceuticals Ltd. (Bangladesh)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sichuan Luye Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • ICU Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • JW Pharmaceutical Corporation (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Hospira, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!